These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6799503)

  • 1. Glutathione depletion sensitizes tumor cells to oxidative cytolysis.
    Arrick BA; Nathan CF; Griffith OW; Cohn ZA
    J Biol Chem; 1982 Feb; 257(3):1231-7. PubMed ID: 6799503
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.
    Hamilton TC; Winker MA; Louie KG; Batist G; Behrens BC; Tsuruo T; Grotzinger KR; McKoy WM; Young RC; Ozols RF
    Biochem Pharmacol; 1985 Jul; 34(14):2583-6. PubMed ID: 4040369
    [No Abstract]   [Full Text] [Related]  

  • 3. Glutathione depletion in tissues after administration of buthionine sulphoximine.
    Minchinton AI; Rojas A; Smith KA; Soranson JA; Shrieve DC; Jones NR; Bremner JC
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1261-4. PubMed ID: 6469748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular glutathione as a determinant of responsiveness to antitumor drugs.
    Romine MT; Kessel D
    Biochem Pharmacol; 1986 Oct; 35(19):3323-6. PubMed ID: 3464280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes.
    Nair S; Singh SV; Samy TS; Krishan A
    Biochem Pharmacol; 1990 Feb; 39(4):723-8. PubMed ID: 2306280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmentalised depletion of glutathione in cells treated with buthionine sulphoximine.
    Edgren M; Révész L
    Br J Radiol; 1987 Jul; 60(715):723-4. PubMed ID: 3620835
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard.
    Somfai-Relle S; Suzukake K; Vistica BP; Vistica DT
    Biochem Pharmacol; 1984 Feb; 33(3):485-90. PubMed ID: 6704165
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic effects of extended glutathione depletion by buthionine sulfoximine on murine mammary carcinoma cells.
    Dethlefsen LA; Biaglow JE; Peck VM; Ridinger DN
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1157-60. PubMed ID: 3744934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine.
    Romero FJ; Sies H
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC; Harris JW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism.
    Medh RD; Gupta V; Awasthi YC
    Biochem Pharmacol; 1991 Jul; 42(2):439-41. PubMed ID: 1859455
    [No Abstract]   [Full Text] [Related]  

  • 14. Marked reduction of rat brain glutathione following intracerebroventricular administration of the glutathione synthesis inhibitor L-buthionine sulfoximine.
    Pileblad E; Magnusson T
    Neurosci Lett; 1988 Dec; 95(1-3):302-6. PubMed ID: 3226616
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H
    Laryngorhinootologie; 1990 Jan; 69(1):16-20. PubMed ID: 2310456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione depletion: does it influence radiosensitization by misonidazole?
    Scott OC
    Br J Radiol; 1986 Mar; 59(699):299-301. PubMed ID: 3947844
    [No Abstract]   [Full Text] [Related]  

  • 19. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts.
    Skapek SX; Colvin OM; Griffith OW; Groothuis DR; Colapinto EV; Lee Y; Hilton J; Elion GB; Bigner DD; Friedman HS
    Biochem Pharmacol; 1988 Nov; 37(22):4313-7. PubMed ID: 3196356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of inhibitors of glutathione and glutathione transferase for overcoming resistance of tumor to cytostatics in an in vivo system].
    Donenko FV; Sitdikova SM; Kabieva AO; Polotskiĭ BE; Machaladze ZO; Davydov MI; Moroz LV
    Biull Eksp Biol Med; 1995 Feb; 119(2):212-4. PubMed ID: 7670058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.